-- U.S. RESEARCH ROUNDUP: Abbott Laboratories, Valero Energy  
-- 
-- Thu Jan 23, 2014 03:30AM EST
-- None



Jan 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbott Laboratories and Valero Energy, on Thursday.

HIGHLIGHTS * Abbott Laboratories <ABT.N>: Leerink raises target to $40 from $37; rating market perform * Valero Energy <VLO.N>: Macquarie raises target price to $69 from $65; rating outperform  Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.   * Abbott Laboratories <ABT.N>: Leerink raises target to $40 from $37; rating market perform * Amphenol Corp <APH.N>: RBC raises target price to $96 from $94; rating top pick * FirstEnergy <FE.N>: BMO cuts target price to $34 from $37; rating market perform * Motorola Solutions <MSI.N>: BMO raises target to $63 from $61; rating market perform * Parker Hannifin <PH.N>: BMO raises target price to $138 from $133; rating outpeform * Raptor Pharmaceutical <RPTP.O>: Leerink raises target to $19 from $17; rating outperform * Renasant Corp <RNST.O>: KBW raises target price to $32 from $28; rating market perform * SanDisk Corp <SNDK.O>: Jefferies raises target price to $85 from $75; rating buy * Southwest Bancorp <OKSB.O>: KBW raises target to $19 from $16.50; rating market perform * Teradyne <TER.N>: Susquehanna raises target price to $23 from $22; rating positive * Texas Capital Bancshares <TCBI.O>: SunTrust raises target to $67 from $63; rating neutral * Valero Energy <VLO.N>: Macquarie raises target price to $69 from $65; rating outperform